Krzysztof Lewandowski

4.7k total citations
177 papers, 3.0k citations indexed

About

Krzysztof Lewandowski is a scholar working on Hematology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Krzysztof Lewandowski has authored 177 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Hematology, 39 papers in Endocrinology, Diabetes and Metabolism and 36 papers in Genetics. Recurrent topics in Krzysztof Lewandowski's work include Chronic Lymphocytic Leukemia Research (19 papers), Chronic Myeloid Leukemia Treatments (19 papers) and Acute Myeloid Leukemia Research (18 papers). Krzysztof Lewandowski is often cited by papers focused on Chronic Lymphocytic Leukemia Research (19 papers), Chronic Myeloid Leukemia Treatments (19 papers) and Acute Myeloid Leukemia Research (18 papers). Krzysztof Lewandowski collaborates with scholars based in Poland, United Kingdom and Germany. Krzysztof Lewandowski's co-authors include Harpal Randeva, Andrzej Lewiñski, Bee K. Tan, Chris J. O’Callaghan, Paul O’Hare, Raghu Adya, Farhatullah Syed, Małgorzata Bieńkiewicz, Gordana M. Prelević and Hendrik Lehnert and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Krzysztof Lewandowski

165 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Krzysztof Lewandowski Poland 26 667 505 486 472 412 177 3.0k
Arnaud François France 31 517 0.8× 241 0.5× 432 0.9× 842 1.8× 158 0.4× 153 3.6k
Angela Silveira Sweden 35 911 1.4× 767 1.5× 345 0.7× 630 1.3× 178 0.4× 103 4.3k
István Karádi Hungary 37 456 0.7× 505 1.0× 351 0.7× 904 1.9× 159 0.4× 140 3.8k
Éric Thervet France 38 462 0.7× 384 0.8× 176 0.4× 766 1.6× 541 1.3× 143 4.9k
Barna Vásárhelyi Hungary 32 346 0.5× 211 0.4× 187 0.4× 457 1.0× 388 0.9× 193 3.0k
Ingiäld Hafström Sweden 39 431 0.6× 731 1.4× 510 1.0× 846 1.8× 125 0.3× 111 4.8k
Pierre‐Yves Scarabin France 39 494 0.7× 804 1.6× 152 0.3× 283 0.6× 694 1.7× 88 5.6k
Georg Endler Austria 34 830 1.2× 793 1.6× 282 0.6× 616 1.3× 118 0.3× 109 3.8k
Kevin V. Lemley United States 36 241 0.4× 180 0.4× 354 0.7× 1.5k 3.2× 326 0.8× 100 5.4k
Ken Tsuchiya Japan 32 283 0.4× 466 0.9× 353 0.7× 964 2.0× 115 0.3× 241 4.2k

Countries citing papers authored by Krzysztof Lewandowski

Since Specialization
Citations

This map shows the geographic impact of Krzysztof Lewandowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krzysztof Lewandowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krzysztof Lewandowski more than expected).

Fields of papers citing papers by Krzysztof Lewandowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krzysztof Lewandowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krzysztof Lewandowski. The network helps show where Krzysztof Lewandowski may publish in the future.

Co-authorship network of co-authors of Krzysztof Lewandowski

This figure shows the co-authorship network connecting the top 25 collaborators of Krzysztof Lewandowski. A scholar is included among the top collaborators of Krzysztof Lewandowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krzysztof Lewandowski. Krzysztof Lewandowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dytfeld, Dominik, et al.. (2025). Should we Cryopreserve Allogenic Hematopoietic Stem Cell Grafts?. In Vivo. 39(2). 870–876.
2.
Lewandowski, Krzysztof, et al.. (2024). The Utility of Intravenous Methylprednisolone as an Adjunct Treatment for Drug-Resistant Amiodarone-Induced Thyrotoxicosis. Journal of Clinical Medicine. 13(2). 324–324.
3.
Prejzner, Witold, Alicja Sadowska‐Klasa, Ewa Zarzycka, et al.. (2023). The role of daratumumab in relapsed/refractory CD38 positive acute leukemias—case report on three cases with a literature review. Frontiers in Oncology. 13. 1228481–1228481. 4 indexed citations
4.
Lewandowski, Krzysztof, et al.. (2022). Rapid progression of myelofibrosis in polycythemia vera patient carrying SRSF2 c.284C>A p.(Pro95His) and unique ASXL1 splice site c.1720‐2A>G variant. Journal of Clinical Laboratory Analysis. 36(5). e24388–e24388. 3 indexed citations
5.
Kowalski, Robert, et al.. (2021). The cAMP Inducers Modify N-Acetylaspartate Metabolism in Wistar Rat Brain. Antioxidants. 10(9). 1404–1404. 1 indexed citations
6.
Kardas, Przemysław & Krzysztof Lewandowski. (2015). Type 2 diabetes patients assessment of the COMODITY12 mHealth system. 325–329. 2 indexed citations
8.
Lewandowski, Krzysztof, et al.. (2012). Successful treatment of thyrotoxicosis is accompanied by a decrease in serum sclerostin levels. 15th International & 14th European Congress of Endocrinology. 29. 1 indexed citations
9.
Lewandowski, Krzysztof, et al.. (2012). Serum concentrations of thrombospondin-1 and adiponectin in patients with hyperthyroidism before and after normalisation of thyroid function. 15th International & 14th European Congress of Endocrinology. 29. 1 indexed citations
10.
Lewandowski, Krzysztof, et al.. (2012). Nilotinib induced complete molecular response in the patient in chronic phase of chronic myeloid leukemia and imatinib intolerance after acetaminophen intake. Via Medica Journals.
11.
Lewandowski, Krzysztof, et al.. (2011). Lipid peroxidation is raised in gestational diabetes: correlation with glucose levels. Diabetologia. 54. 1 indexed citations
12.
Lewandowski, Krzysztof, et al.. (2010). GnRH test as an additional investigation in the diagnosis of polycystic ovary syndrome (PCOS): potential application of stimulated LH/FSH ratio. Endocrine Abstracts. 22. 2 indexed citations
13.
Lewandowski, Krzysztof, Katarzyna Cypryk, Andrzej Lewiñski, et al.. (2010). Positive correlation between serum omentin and thrombospondin-1 in gestational diabetes despite lack of correlation with insulin resistance indices. Via Medica Journals. 21. 1 indexed citations
14.
Tan, Bee K., Jing Chen, Raghu Adya, et al.. (2009). Insulin increases and metformin decreases the novel adipokine chemerin in insulin resistant subjects: PCOS as a paradigm. 19. 1 indexed citations
15.
Lewandowski, Krzysztof, et al.. (2009). Concentrations of matrix metalloproteinase 2 and 9 in patients with type 2 diabetes and in non-diabetic controls. 19. 1 indexed citations
16.
Karbownik‐Lewińska, Małgorzata, et al.. (2007). GH replacement reduces increased lipid peroxidation in GH‐deficient adults. Clinical Endocrinology. 68(6). 957–964. 10 indexed citations
17.
Krawczyk, Beata & Krzysztof Lewandowski. (2007). Optimalization and validation of ADSRRS-fingerprinting. Biotechnologia. 95–113. 1 indexed citations
18.
Lewandowski, Krzysztof, Konrad Szosland, R. Horn, Georg Brabant, & Andrzej Lewiñski. (2006). Short-term lifestyle intervention significantly increases fasting adiponectin and induces a decline in serum adiponectin during oral glucose tolerance test without changes in insulin resistance. Archives of Medical Science. 2(3). 179–184. 1 indexed citations
19.
Lewandowski, Krzysztof, et al.. (2005). Effect of timing of prolactin sampling on the incidence of spurious hyperprolactinaemia. 9. 3 indexed citations
20.
Januszkiewicz‐Lewandowska, Danuta, et al.. (2003). Transmission of HCV infection among long-term hospitalized onco-haematological patients. Journal of Hospital Infection. 53(2). 120–123. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026